Read OSN’s Dec. 25 publication exclusives online

The cover story in the Dec. 25, 2018, issue of Ocular Surgery News focused on the FDA approval process for ophthalmology in 2018.

Here are some of the issue’s publication exclusives:

Cover Story

Improved communication evident in FDA approval process for 2018

More meaningful endpoints for clinical trials, better communication for necessary study designs and an improved approval process have led to more efficient FDA approvals for ophthalmologic drugs and devices in 2018. Read more.

Lindstrom’s Perspective

Future looks optimistic for ophthalmology

Thanks to the efforts of Wiley Chambers, MD, Malvina Eydelman, MD, and their teams charged with approving new ophthalmic drugs and devices, 2017 and 2018 in the field of ophthalmology were banner years. Read more.

Point/Counter

What possible FDA approval in 2019 do you believe will have the most impact on ophthalmology?

Kathryn M. Hatch, MD, and Jennifer Loh, MD, offer their takes on the topic. Read more.

Back to Basics

The secret to a great capsulorrhexis

When we examine an eye that had previous cataract surgery years ago, we see two things: the incision and the capsulorrhexis. And based on those, we sometimes make a judgment as to the skills of the previous surgeon. Read more.

Grand Rounds at the New England Eye Center

Woman presents with ocular pain, redness and photophobia

Exam reveals a corneal epithelial defect with surrounding edema and Descemet’s folds, and a dense white ring infiltrate. Read more.